These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9642544)

  • 21. Cognitive disorders and antiphospholipid antibodies.
    Yelnik CM; Kozora E; Appenzeller S
    Autoimmun Rev; 2016 Dec; 15(12):1193-1198. PubMed ID: 27639839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antiribosomal antibodies and the neurological manifestations in systemic lupus erythematosus].
    Wichmann Schlipf I; Sánchez Román J; Castillo Palma MJ; Varela Aguilar JM; Martino Albornoz C; Tena Soto N; Núñez Roldán A
    Med Clin (Barc); 1993 Jan; 100(3):81-3. PubMed ID: 8426498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-N-methyl-D-aspartate receptor and anti-ribosomal-P autoantibodies contribute to cognitive dysfunction in systemic lupus erythematosus.
    Massardo L; Bravo-Zehnder M; Calderón J; Flores P; Padilla O; Aguirre JM; Scoriels L; González A
    Lupus; 2015 May; 24(6):558-68. PubMed ID: 25318968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of depressive and anxiety disorders in systemic lupus erythematosus and their association with anti-ribosomal P antibodies.
    Nery FG; Borba EF; Viana VS; Hatch JP; Soares JC; Bonfá E; Neto FL
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):695-700. PubMed ID: 18077068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential roles of the anti-ribosomal P antibody and antineuronal antibody in the pathogenesis of central nervous system involvement in systemic lupus erythematosus.
    Isshi K; Hirohata S
    Arthritis Rheum; 1998 Oct; 41(10):1819-27. PubMed ID: 9778223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positron emission tomography and magnetic resonance imaging for cerebral involvement in patients with systemic lupus erythematosus.
    Sailer M; Burchert W; Ehrenheim C; Smid HG; Haas J; Wildhagen K; Wurster U; Deicher H
    J Neurol; 1997 Mar; 244(3):186-93. PubMed ID: 9050960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are antibodies to ribosomal P proteins a clinically useful predictor of neuropsychiatric manifestations in patients with systemic lupus erythematosus?
    Iverson GL
    Lupus; 1996 Dec; 5(6):634-5. PubMed ID: 9116712
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
    Cabiedes J; Cabral AR; Alarcón-Segovia D
    J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Neurological and psychiatric manifestations of systemic lupus erythematosus and antiphospholipid syndrome].
    Aszalós Z
    Orv Hetil; 2011 Apr; 152(15):597-605. PubMed ID: 21436024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibodies against gangliosides in patients with SLE and neurological manifestations.
    Martinez X; Tintoré M; Montalbán J; Ordi J; Vilardell M; Codina A
    Lupus; 1992 Oct; 1(5):299-302. PubMed ID: 1303222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive impairment, event-related potentials and immunological status in patients with systemic lupus erythematosus.
    Szmyrka M; Pokryszko-Dragan A; Słotwiński K; Gruszka E; Korman L; Podemski R; Wiland P
    Adv Clin Exp Med; 2019 Feb; 28(2):185-192. PubMed ID: 29963787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of cognitive dysfunction in patients with systemic lupus erythematosus.
    McLaurin EY; Holliday SL; Williams P; Brey RL
    Neurology; 2005 Jan; 64(2):297-303. PubMed ID: 15668428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Neurologic manifestations associated with antiphospholipid antibodies. Or what remains of neurolupus?].
    Hachulla E; Leys D; Deleume JF; Pruvo JP; Devulder B
    Rev Med Interne; 1995; 16(2):121-30. PubMed ID: 7709101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A close temporal relationship of liver disease to antiribosomal P0 protein antibodies and central nervous system disease in patients with systemic lupus erythematosus.
    Yoshio T; Masuyama JI; Minota S; Kaneko N; Iwamoto M; Okazaki H; Mimori A; Takeda A; Kano S
    J Rheumatol; 1998 Apr; 25(4):681-8. PubMed ID: 9558169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibodies and clinical features of the antiphospholipid syndrome as criteria for systemic lupus erythematosus.
    Merrill JT
    Lupus; 2004; 13(11):869-76. PubMed ID: 15580985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Anti-ribosomal antibodies in systemic lupus erythematosus].
    Corres González JM; Rodríguez Hernández C; Zea Mendoza AC; Sequí Navarro J; Sanchidrián Fernández I
    Rev Clin Esp; 1995 Jan; 195(1):16-21. PubMed ID: 7878261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of anti-ribosomal P protein antibodies with neuropsychiatric systemic lupus erythematosus.
    Isshi K; Hirohata S
    Arthritis Rheum; 1996 Sep; 39(9):1483-90. PubMed ID: 8814059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. International survey on the management of patients with SLE. II. The results of a questionnaire regarding neuropsychiatric manifestations.
    Tincani A; Brey R; Balestrieri G; Vitali C; Doria A; Galeazzi M; Meroni PL; Migliorini P; Neri R; Tavoni A; Bombardieri S
    Clin Exp Rheumatol; 1996; 14 Suppl 16():S23-9. PubMed ID: 9049450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cognitive dysfunction in patients with systemic lupus erythemathosus with or without antiphospholipid antibodies].
    Cibicková L; Soukup T; Cermáková E; Bradna P; Hrncír Z
    Vnitr Lek; 2007 Mar; 53(3):242-5. PubMed ID: 17503637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.